Teresa De Luca
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Histone Deacetylase Inhibitors Research, Epigenetics and DNA Methylation, Autophagy in Disease and Therapy, RNA Interference and Gene Delivery
Most-Cited Works
- → 1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells(2014)131 cited
- → Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma(2017)70 cited
- → Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells(2011)68 cited
- → Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer(2014)67 cited
- → PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer(2017)54 cited
- → Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells(2016)53 cited
- → miR‐211 and MITF modulation by Bcl‐2 protein in melanoma cells(2015)37 cited
- → Removal of the BH4 Domain from Bcl-2 Protein Triggers an Autophagic Process that Impairs Tumor Growth(2013)36 cited
- → Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models(2018)34 cited
- → The thiazole derivative CPTH6 impairs autophagy(2013)33 cited